# T Stamp Inc: overview IDAI · Nasdaq · CIK 1718939 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/idai.md) · [Financials](/companies/idai/financials.md) · [Filings](/companies/idai/filings.md) · [Insiders](/companies/idai/insiders.md) Latest reported revenue: [$899.9k](/filings/0001718939-26-000053.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001718939-26-000053). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [511](/filings/0001718939-25-000163.md) | [1,497 d](/filings/0001718939-26-000024.md) | [545](/filings/0001718939-26-000029.md) | [813](/filings/0001718939-26-000053.md) | [872](/filings/0001718939-25-000163.md) | [909 d](/filings/0001718939-26-000024.md) | [757](/filings/0001718939-26-000029.md) | [900](/filings/0001718939-26-000053.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(523.7%)](/filings/0001718939-25-000163.md) | [(81.2%) d](/filings/0001718939-26-000024.md) | [(396.5%)](/filings/0001718939-26-000029.md) | [(207.0%)](/filings/0001718939-26-000053.md) | [(203.0%)](/filings/0001718939-25-000163.md) | [(224.9%) d](/filings/0001718939-26-000024.md) | [(299.8%)](/filings/0001718939-26-000029.md) | [(266.4%)](/filings/0001718939-26-000053.md) | | Net margin | % | [(245.7%)](/filings/0001718939-25-000163.md) | [(401.5%) d](/filings/0001718939-26-000024.md) | [(395.5%)](/filings/0001718939-26-000029.md) | [(210.7%)](/filings/0001718939-26-000053.md) | [(219.1%)](/filings/0001718939-25-000163.md) | [(916.5%) d](/filings/0001718939-26-000024.md) | [(294.8%)](/filings/0001718939-26-000029.md) | [(299.3%)](/filings/0001718939-26-000053.md) | | Diluted EPS | $ per share | [(1.06)](/filings/0001718939-25-000163.md) | not reported | [(0.89)](/filings/0001718939-26-000029.md) | [(0.69)](/filings/0001718939-26-000053.md) | [(0.72)](/filings/0001718939-25-000163.md) | not reported | [(0.42)](/filings/0001718939-26-000029.md) | [(0.48)](/filings/0001718939-26-000053.md) | | Free cash flow | $k | [(2,430) d](/filings/0001718939-25-000163.md) | [(2,738) d](/filings/0001718939-26-000024.md) | [(1,577)](/filings/0001718939-26-000029.md) | [(2,102) d](/filings/0001718939-25-000139.md) | [(4,010) d](/filings/0001718939-25-000163.md) | [(1,678) d](/filings/0001718939-26-000024.md) | [(1,881)](/filings/0001718939-26-000029.md) | [(2,239) d](/filings/0001718939-26-000053.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [3,678](/filings/0001410578-23-000453.md) | [5,385](/filings/0001718939-24-000043.md) | [4,560](/filings/0001718939-25-000080.md) | [3,082](/filings/0001718939-26-000024.md) | [3,139](/filings/0001718939-26-000024.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(241.7%)](/filings/0001410578-23-000453.md) | [(224.3%)](/filings/0001718939-24-000043.md) | [(173.0%)](/filings/0001718939-25-000080.md) | [(303.9%)](/filings/0001718939-26-000024.md) | [(244.0%)](/filings/0001718939-26-000024.md) | | Net margin | % | [(246.3%)](/filings/0001410578-23-000453.md) | [(224.5%)](/filings/0001718939-24-000043.md) | [(167.5%)](/filings/0001718939-25-000080.md) | [(407.0%)](/filings/0001718939-26-000024.md) | [(265.2%)](/filings/0001718939-26-000024.md) | | Diluted EPS | $ per share | [(2.40)](/filings/0001410578-23-000453.md) | [(2.55)](/filings/0001718939-24-000043.md) | [(16.07)](/filings/0001718939-25-000080.md) | [(11.36)](/filings/0001718939-26-000024.md) | [(2.67)](/filings/0001718939-26-000024.md) | | Free cash flow | $k | [(6,736)](/filings/0001410578-23-000453.md) | [(6,368)](/filings/0001718939-24-000043.md) | [(7,857)](/filings/0001718939-25-000080.md) | [(8,934)](/filings/0001718939-26-000024.md) | [(5,731)](/filings/0001718939-26-000024.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/idai/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Kestra Advisory Services, LLC](/funds/1830819.md) | 2026-06-30 | $96.4k | 48,700 | | Reduced −7,350 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $93.5k | 47,234 | | Reduced −56,429 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $78.5k | 39,624 | | Added +21,324 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $69.0k | 34,863 | | Unchanged | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $50.6k | 25,537 | | New +25,537 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $48.1k | 24,277 | | Reduced −79,573 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $44.3k | 22,359 | | Unchanged | | [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $36.3k | 18,351 | | New +18,351 | | [C2C Wealth Management, LLC](/funds/1868903.md) | 2026-06-30 | $19.8k | 10,000 | | New +10,000 | | [MidFirst Bank](/funds/2077076.md) | 2026-06-30 | $15.0k | 7,600 | | Unchanged | ## Recent filings [All 459 filings](/companies/idai/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-27 | 09:14 ET | [8-K](/filings/0001718939-26-000062.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001718939-26-000062 | | 2026-10-09 | 16:40 ET | [8-K](/filings/0001718939-26-000060.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001718939-26-000060 | | 2026-08-13 | 16:11 ET | [8-K](/filings/0001718939-26-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001718939-26-000054 | | 2026-08-13 | 16:10 ET | [10-Q](/filings/0001718939-26-000053.md) | Quarterly report, period 2026-06-30 | 0001718939-26-000053 | | 2026-07-23 | 13:20 ET | [8-K](/filings/0001718939-26-000045.md) | 8.01 Other events | 0001718939-26-000045 | | 2026-07-10 | 16:25 ET | [8-K](/filings/0001718939-26-000042.md) | 8.01 Other events | 0001718939-26-000042 | | 2026-06-25 | 13:47 ET | [8-K](/filings/0001718939-26-000039.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001718939-26-000039 | | 2026-05-20 | 16:30 ET | [DEF 14A](/filings/0001718939-26-000035.md) | Proxy statement, period 2026-05-20 | 0001718939-26-000035 | | 2026-05-14 | 16:28 ET | [8-K](/filings/0001718939-26-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001718939-26-000030 | | 2026-05-14 | 16:28 ET | [10-Q](/filings/0001718939-26-000029.md) | Quarterly report, period 2026-03-31 | 0001718939-26-000029 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001718939-26-000024.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/f85a8bdd-d6b3-4261-8520-2928eeca981d) ## About the filer - CIK: 1718939 - Tickers: IDAI - Exchange: Nasdaq - SIC code: 7372 Services-Prepackaged Software - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 09:31 ET. No prices; not investment advice.